Safety and Efficacy Study of Cyclosporine Ophthalmic Emulsion in Post-LASIK Patients

Completed · Phase 2

Conditions studied: Dry Eye Syndromes

In brief

This study will evaluate the safety and efficacy of cyclosporine ophthalmic emulsion administered twice daily following LASIK surgery

Key facts

Study ID

NCT00611403

Run by

Allergan

People needed

137

Starts

2007-12-01

Expected to finish

2009-06-01

Last updated by the study team

2011-12-20

Who can join

Age: 21 and older, up to 50. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient is scheduled for bilateral LASIK surgery
• Patient is in good general health
• Eye glasses prescription of -1 to -8

You may not qualify if…

• Significant Dry Eye
• Presence of eye disease
• Uncontrolled systemic disease

Where it is running

• Study site — Overland Park, Kansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.